Regulatory News
Tuesday, January 17, 2017
FDA approves generic version of Jazz Pharma's sleep disorder drug
Jan 17 (Reuters) - The U.S. Food and Drug Administration
said on Tuesday it had approved the first generic version of
Xyrem, Jazz Pharmaceuticals Plc's drug to treat
patients with a medical condition...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment